Key statistics
As of last trade Supernus Pharmaceuticals Inc (S49:MUN) traded at 46.72, -3.48% below its 52-week high of 48.40, set on Oct 31, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 46.72 |
|---|---|
| High | 46.72 |
| Low | 46.72 |
| Bid | 45.99 |
| Offer | 46.41 |
| Previous close | 47.36 |
| Average volume | 87.71 |
|---|---|
| Shares outstanding | 57.46m |
| Free float | 54.82m |
| P/E (TTM) | -- |
| Market cap | 3.14bn USD |
| EPS (TTM) | -0.6839 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:04 GMT.
More ▼
- Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
- Supernus Pharmaceuticals to Participate in March Investor Conferences
- Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
- Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
- Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
- Supernus Announces Third Quarter 2025 Financial Results
- Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
- Supernus Pharmaceuticals to Participate in September Investor Conferences
- Supernus Announces Second Quarter 2025 Financial Results
More ▼
